Search

everythinglearnresearchcommunity

for

Search:↓

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Nanotechnology improves minoxidil treatment for hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

Miscanthus sinensis flower extract may help promote hair growth and prevent hair loss.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

Exosomes show promise for future tissue regeneration.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Innovative methods are reducing animal testing and improving biomedical research.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

Some nutrients and antioxidants may improve skin and hair health, but more research is needed to confirm these benefits.